Correction of functional capacity of myocardium in arterial hypertension associated with hyperuricemia and poikilocytosis comorbidities
DOI:
https://doi.org/10.14739/2310-1210.2019.4.173151Keywords:
arterial hypertension, hyperuricemia, abnormal erythrocytes, left ventricular function, laser therapyAbstract
Aim. To study the influence of hyperuricemia (HU) on the functional capacity of the myocardium and erythrocytes morphology in patients with arterial hypertension (AH) and to estimate the possibility of their correction using low-level laser therapy (LLLT).
Materials and methods. A total of 82 patients with AH were divided into two groups depending on the level of uric acid (UA): group AH – 40 patients with AH and normal UA level; group HU + AH – 42 patients with AH in combination with HU. Scanning electron microscopy, 24-hour blood pressure monitoring and echocardiography were performed. LLLT course was performed for the therapeutic purpose.
Results. A significantly increased degree of poikilocytosis up to 24.4 % of patients in the AH + HU group was caused by HU compared with 17.7 % of patients in the AH group. A moderate direct correlation was established between the level of UA, poikilocytosis and Tei index. After LLLT, poikilocytosis was reduced by 15.1 % in the AH group and by 29.9 % in the AH + HU group. The decrease in UA was 18.7 % in the group AH + HU and 3.9 % in the AH group. The significant unidirectional dynamics of UA indices (Δ% –18.7) and poikilocytosis (Δ% –29.9) in the group AH + HU has proved the role of UA in the development of poikilocytosis.
After the treatment, the mean daily SBP was 8.2–9.0 % decreased in both groups, and Tei index was decreased by 29.3 % in the AH + HU group and by 9.5 % in the AH group.
Conclusions. The use of LILT can significantly reduce the level of UA, degree of poikilocytosis, BP, and thus improve the functional capacity of the left ventricular myocardium in AH patients with hyperuricemia and poikilocytosis comorbidities.
References
Zipes, D., & Libby, P. (2018) Libby Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine.
Shalnova1, S. A., Deev, A. D., Artamonov, G. V., Duplyakov, D. V., Efanov, A. Y., Zhernakova, Y. V., et al. (2014) Giperurikemiya i eyo korelyaty v rossijskoj populyacii (rezul'taty e'pidemiologicheskogo issledovaniya E'SSE-RF) [Hyperuricemia and its correlates in the Russian population (results of ESSE-RF epidemiological study)]. Racional'naya Farmakoterapiya v Kardiologii, 10(2), 153–159. [in Russian]. https://doi.org/10.20996/1819-6446-2014-10-2-153-159
Smiianov, V., Witczak, I., Smiianova, O., & Rudenko, L. (2017) Monitoring of awareness level in dispensary patients with arterial hypertension. Wiadomosci Lekarskie, 70(2 pt 2), 299–302.
Gyawali, P., Richards, R. S., Hughes, D. L., & Tinley, P. (2014) Erythrocyte aggregation and metabolic syndrome. Clin Hemorheol Microcirc., 57(1), 73–83. doi: 10.3233/CH-131792.
Luo, M., Li, Z. Z., Li, Y. Y., Chen, L.-Z., Yan, Sh.-P., Chen, P., & Hu, Y.-Y. (2014) Relationship between red cell distribution width and serum uric acid in patients with untreated essential hypertension. Sci Rep., 4, 7291. doi: 10.1038/srep07291
Zhang, C., Meng, Z., Li, X., Liu, M., Ren, X., Zhu, M., et al. (2018) No associations exists between red blood cell distribution width and serum uric acid in both sexes. Medicine (Baltimore), 97(40), e12707. doi: 10.1097/MD.0000000000012707
Krishnan, E. (2012) Gout and the risk for incident heart failure and systolic dysfunction. BMJ Open., 2(1), e000282. doi: 10.1136/bmjopen-2011-000282
Anandbir Singh Bath, & Vishal Gupta (2019) Cardio-light: nitric oxide uncaged. Lasers in Medical Science, 34(2), 405–409.
Pasternak, K., Nowacka, O., Wróbel, D., Email, P., Bryszewska, M., & Kujawa J. (2014) Influence of MLS laser radiation on erythrocyte membrane fluidity and secondary structure of human serum albumin. Molecular and Cellular Biochemistry, 388(1–2), 261–267.
Nakaz MOZ Ukrainy «Pro zatverdzhennia ta vprovadzhennia medyko-tekhnolohichnykh dokumentiv zi standartyzatsii medychnoi dopomohy pry arterialnii hipertenzii» vid 24.05.2012 r. №384 [Order of the Ministry of Health of Ukraine «On Approval and Implementation of Medical-Technological Documents for the Standardization of Medical Assistance in Arterial Hypertension» from May 24, 2012, №384] [in Ukrainian].
Tham, E. B., & Silverman, N. H. (2004) Measurement of the Tei index: a comparison of M-mode and pulse Doppler methods. Journal of the American Society of Echocardiography, 17(12), 1259–1265. doi: 10.1016/j.echo.2004.07.009
Williams, B., Mancia, G., Spiering, W., Agabiti Rosei, E., Azizi, M., Burnier, M., et al. (2018) 2018 ESH / ESC Guidelines for the management of arterial hypertension. European Heart Journal, 39(33), 3021–3104. doi: 10.1093/eurheartj/ehy339
Hoffman, R., Benz, E. J., Silberstein. L. E., Heslop, H. E., Weitz, J. I., Anastasi, J., & Abutalib, S. A. (2018). Hematology (Seventh Edition), P. 2374 Retrieved from https://doi.org/10.1016/B978-0-323-35762-3.00165-7
Bajbekov, I. M., Mavlyan-Khodzhaev, R.Sh., E'rstekis, A. G., & Moskvin, S. V. (2008) E'ritrocity v norme, patologii i pri lazernykh vozdejstviyakh [Erythrocytes in normal, pathological and laser conditions]. Tver': Triada. [in Russian].
Sloop, G. D., Bialczak, J. K., Weidman, J. J., & St Cyr, J. A. (2016) Uric acid increases erythrocyte aggregation: Implications for cardiovascular disease. Clinical Hemorheology and Microcirculation, 63(4), 349–359. doi: 10.3233/CH-152023
Reinhart, W. H., Singh-Marchetti, M., & Straub, P. W. (1992) The influence of erythrocyte shape on suspension viscosities. Eur J Clin Invest., 22(1). 38–44. doi: 10.1111/j.1365-2362.1992.tb01933.x
Piety, N. Z., Reinhart, W. H., Pourreau, P. H., Abidi, R., & Shevkoplyas, S. S. (2016) Shape matters: the effect of red blood cell shape on perfusion of an artificial microvascular network. Transfusion, 56(4), 844–851. doi: 10.1111 / trf.13449
Liu, D., Fernandez, B. O., Hamilton, A., Lang, N. N., Gallagher, J. M. C., Newby, D. E., et al. (2014) UVA irradiation of human skin vasodilates arterial vasculature and lowers blood pressure independently of nitric oxide synthase. J Invest Dermatol, 134(7), 1839–1846. doi: 10.1038/jid.2014.27
Koumaras, C., Tziomalos, K., Stavrinou, E., Katsiki, N., Athyros, V. G., Mikhailidis, D. P., & Karagiannis, A. (2014) Effects of renin-angiotensin-aldosterone system inhibitors and beta-blockers on markers of arterial stiffness. Journal of the American Society of Hypertension. 8(2), 74–82. doi: 10.1016/j.jash.2013.09.001
Tuncer, M., Guntekin, U., Gunes, Y., Gumrukcuoglu, H. A., & Eryonucu, B. (2008) Differential effects of nebivolol and atenolol on transmitral diastolic filling parameters in patientswith essential hypertension. Adv Therapy., 25(6), 619–26. doi: 10.1007/s12325-008-0065-3
Manchini, M. T., Serra, A. J., Feliciano Rdos, S., Santana, E. T., Antônio, E. L., de Tarso Camillo de Carvalho, P., et al. (2014) Amelioration of cardiac function and activation of anti-inflammatory vasoactive peptides expression in the rat myocardium by low level laser therapy. PLoS One., 9(7), e101270. doi: 10.1371/journal.pone.0101270
Downloads
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)
